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Objectives: Recent publications have discussed the risk of
deep venous thrombosis during laparoscopic cholecystec-
tomy and the need for routine deep venous thrombosis
(DVT) prophylaxis. The purpose of this study was to
determine the incidence of clinically detectable DVT in
patients undergoing laparoscopic cholecystectomy with-
out a standard DVT prophylaxis regimen.
Materials and Methods: We  performed completed
laparoscopic cholecystectomy in 587 patients over a 4-year
period. Eighteen of these patients received some form of
perioperative DVT prophylaxis, and 569 patients did not.
Routine screening with a duplex Doppler was not used.
Patients were followed postoperatively for 4 weeks after
discharge from the hospital.
Results: In an average of 4 weeks follow-up, 31 compli-
cations and 4 deaths were reported. These complications
included wound infection (16), postoperative bleeding (3),
persistent pain (3), pneumonia (3), retained CBD stones
(2), asthma (1), papillary stenosis (1), ileus (1), and intra-
operative bowel injury (1). None of the 587 patients in this
study had symptoms of DVT or pulmonary embolism.
Discussion: Despite the fact that DVT in this patient pop-
ulation is rare, many reports suggest the use of routine
DVT prophylaxis with sequential compression devices
(SCDs) or low-molecular-weight heparin (LMWH).
Because no clinically detectable evidence was found of
DVT in our study group despite the lack of any perioper-
ative DVT prophylaxis, we question whether routine DVT
prophylaxis is indicated or cost effective for routine
laparoscopic cholecystectomy. A large prospective trial
addressing this question is needed.
Key Words: Laparoscopy, Cholecystectomy, Deep venous
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INTRODUCTION
Recent publications have described the risk of deep
venous thrombosis (DVT) during laparoscopic cholecys-
tectomy and the need for routine prophylaxis. Both
hypercoagulation and venous stasis during this proce-
dure have been indicated as risk factors.1-5 However, the
true incidence of DVT with routine screening is contro-
versial, but the incidence of clinically detectable DVT is
thought to be small.1-10 Despite this low incidence of
clinically detectable DVT and pulmonary embolism (PE)
in many large review studies, 60% of surgeons select
some form of DVT prophylaxis for laparoscopic chole-
cystectomy.5 Using routine DVT prophylaxis regardless
of the individual risk factors exposes patients to the risks
of anticoagulation and can lead to a substantial increase
in the cost of the procedure. If the incidence of DVT is
truly negligible, prophylaxis may not be indicated. The
purpose of this review was to determine the incidence of
clinically detectable DVT in patients undergoing laparo-
scopic cholecystectomy without a standard DVT prophy-
laxis regimen. 
METHODS
A retrospective chart review was performed of all
patients who underwent a completed laparoscopic
cholecystectomy between July 1, 1996 and July 1, 2000.
Charts were reviewed for age, sex, acute versus chronic
disease, calculous versus acalculous disease, obstructive
symptoms, the presence of common bile duct stones,
endoscopic retrograde cholangio-pancreatography pre-
operatively or postoperatively, operative times, follow-
up intervals, complications, and any use of DVT prophy-
laxis (sequential compression devices, low-molecular-
weight heparin, heparin, or coumadin). With the assis-
tance of general surgical residents, 5 surgeons performed
587 procedures. Prophylaxis against DVT was used in 18
high-risk patients (ie, patients with 1 or more of the fol-
lowing risk factors: malignancy, prolonged immobiliza-
tion, morbid obesity, or a history of DVT). The remain-
ing group of 569 patients, considered low-risk for DVT,
underwent laparoscopic cholecystectomy without receiv-
ing any form of perioperative DVT prophylaxis other
than early ambulation. Routine screening with a duplex
Doppler or radiolabeled fibrinogen was not used.
Methodist Medical Center of Dallas, Department of Surgery (all authors).
Methodist Hospitals of Dallas, Department of Medical Education, General Surgery,
Dallas, Texas 75203 USA. 
Address reprint request to: Ernest Dunn, MD, Methodist Hospitals of Dallas,
Department of Medical Education, General Surgery, 1441 N. Beckley, Dallas, TX
75203 USA. Telephone: (214) 947-2303, Fax: (214) 947-2334
© 2001 by JSLS, Journal of the Society of Laparoendoscopic Surgeons.  Published by
the Society of Laparoendoscopic Surgeons, Inc.
Anna-Maria Blake, MD, Steven I. Toker, Ernest Dunn, MDDeep Venous Thrombosis Prophylaxis is not Indicated for Laparoscopic Cholecystectomy, Blake A-M et al.
216 JSLS(2001)5:215-219
Access to the abdominal cavity was uniformly achieved
by an open Hassan technique. All cases were performed
with patients in the reverse Trendelenburg position with
an intraperitoneal pressure of 12 mm Hg to 15 mm Hg.
Intraoperative cholangiograms were obtained when felt
to be clinically relevant (preoperative suspicion of com-
mon duct stone or intraoperative need to define bile duct
anatomy). Operative times and the use of DVT prophy-
laxis were recorded in the hospital chart. Patients with
chronic cholecystitis were routinely operated on as out-
patients with less than a 23-hour hospital stay, and those
with acute or complicated cholecystitis were admitted to
the hospital and discharged home when stable. All
patients were encouraged to ambulate in the immediate
postoperative time period.
Patients were followed in the physician’s office for at
least 1 return visit. All complaints and unusual physical
findings were recorded in the office chart for review. All
subsequent hospital admissions were then reviewed for
potential association with the original procedure. 
RESULTS
Completed laparoscopic cholecystectomy was performed
in 587 patients (463 females, 124 males) (average age 45
years) (range 16-97 years for day-surgery patients, aver-
age age 44 years) (average age 45.6 years for inpatients)
from July 1, 1996 to July 1, 2000 (Table 1). Day-surgery
patients included 342 patients (270 women, 72 men) who
underwent completed laparoscopic cholecystectomy, and
inpatients included 245 patients (191 women, 54 men)
who underwent laparoscopic cholecystectomy. The aver-
age anesthesia time for all cases was 84 minutes (range
40 minutes to 160 minutes with an average of 81 minutes
for outpatients and 88 minutes for inpatients). Average
length of stay for all patients was 2.1 days. Patients from
day-surgery stayed less than 23 hours in the hospital.
Patients admitted to the hospital had an average length of
stay of 4.3 days (range 1 day to 22 days). DVT prophy-
laxis was given to 18 patients overall, 17 inpatients (13
SCDs, 2 LMWH, 2 coumadin) and 1 day-surgery patient
(low-molecular-weight heparin). All patients were fol-
lowed as outpatients for an average of 4 weeks postop-
eratively for the development of complications.
The indication for laparoscopic cholecystectomy in day-
surgery was chronic biliary colic with cholelithiasis in 243
patients (Table 2). Forty-five patients underwent chole-
cystectomy for biliary dyskinesia. The most common indi-
cation for laparoscopic cholecystectomy in hospitalized
patients was acute cholecystitis with cholelithiasis (175
patients). In addition, 27 patients had known underlying
chronic cholelithiasis prior to admission for acute chole-
cystitis. Ten hospitalized patients underwent laparoscop-
ic cholecystectomy for biliary dyskinesia. Acute acalcu-
lous cholecystitis was found exclusively in the inpatient
population, representing only 8 cases.
Intraoperative cholangiograms (IOC) were performed
when patients were suspected of having choledo-
cholithiasis, such as jaundice, pancreatitis, elevated liver
function tests (LFTs), or cholangitis. Overall, 137 cholan-
giograms were performed (65 for associated pancreatitis,
61 for elevated LFTs, 10 for jaundice alone, and 1 for
cholangitis). Thirty-five outpatients underwent cholan-
giography (5 for pancreatitis and 30 for elevated LFTs).
None of these patients had common bile duct stones.
Table 1.
Comparison of patient age, operative time, and DVT
prophylaxis between day-surgery and hospitalized patients.
Total Day-Surgery Inpatients
Number of Patients 587 342 245
Number of Women 463 272 191
Number of Men 124 70 54
Average Age 45 44 45.6
Anesthesia Time (Minutes) 82 81 88
Length of Stay (Days) 2.1 0.5 4.3
DVT Prophylaxis 18 1 17
Weeks Follow-up 4 4 4
Table 2.
Indications for laparoscopic cholecystectomy for both
day-surgery and hospitalized patients.
Total Day-Surgery Inpatients
Acute Cholecystitis 218 43 175
Acute and Chronic
Cholecystitis 38 11 27
Chronic Cholecystitis 268 243 25
Acute Acalculous
Cholecystitis 8 0 8
Biliary Dyskinesia 55 45 10Endoscopic retrograde cholangio-pancreatography
(ERCP) was performed postoperatively in 2 patients, 1
for a retained common bile duct stone not seen with IOC
and 1 for recurrent symptoms of pain. IOC was per-
formed in 102 hospitalized patients (60 for acute pancre-
atitis, 31 for elevated LFTs, 10 for elevated bilirubin, and
1 for ascending cholangitis). This demonstrated 28
patients with common duct stones, leading to 10 laparo-
scopic common bile duct explorations, and postoperative
ERCP with stone extraction for the remaining 18 patients.
Twenty-eight preoperative ERCPs demonstrated 24
patients with common duct stones. After ERCP with stone
extraction, all IOCs were negative.
The most common complaints after surgery were gas-
trointestinal in nature, most often for diarrhea (21 cases).
The only intraoperative complication was a bowel injury
during placement of a Hassan port in a patient with mul-
tiple abdominal adhesions. This injury was immediately
identified and repaired prior to completion of laparo-
scopic cholecystectomy. The patient recovered unevent-
fully. In an average of 4 weeks follow-up, 30 postopera-
tive complications and 2 deaths were reported. These
complications included infection (16), persistent pain (3),
postoperative bleeding (3), pneumonia (3), retained CBD
stone (2), asthma exacerbation (1), ileus (1), and papil-
lary stenosis (1). Of the patients with wound infection
complications, 2 had infected IV sites, and another 2 had
to be readmitted for parenteral antibiotics for incisional
infections. The remaining 12 wound infections cleared
with oral antibiotics on an outpatient basis. Three
patients were readmitted with symptoms of biliary
obstruction. Two had retained common bile duct stones.
These stones were extracted during ERCP evaluation
without incidence. The remaining patient had a papillary
stenosis of the distal CBD that was treated with biliary
stenting at the time of ERCP. This stenosis was not relat-
ed to the original surgery. Postoperative bleeding was a
complicating factor for 3 patients with end-stage renal
failure, all of whom underwent reexploration and place-
ment of drains. Four pulmonary complications occurred,
including 1 asthma exacerbation (resolved with nebuliz-
er treatment) and 3 pneumonias. Two of these patients
were elderly with multiple medical problems and were
admitted for biliary pancreatitis. After prolonged hospital
courses, both of these patients progressed to pulmonary
sepsis and died.
Perioperative DVT prophylaxis other than early ambula-
tion was not given to 569 of 587 patients, but 18 patients
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received either LMWH or SCDs based on the presence of
various risk factors including: obesity (13), immobility
(3), history of prior DVT (1), and malignancy (1). Patients
were followed for at least 1 visit in an outpatient setting
over an average of 4 weeks postoperatively. No patient
developed symptoms of either DVT or PE. Routine
duplex Doppler examinations or radiolabeled fibrinogen
assays were not used.
DISCUSSION
The risk of developing deep venous thrombosis (DVT)
increases with the number of risk factors present.11 For
the general surgical population, the risk factors for DVT
include a history of prior DVT or pulmonary embolism
(PE), the presence of a malignancy, age over 40, pro-
longed immobilization, obesity, and prolonged exposure
to general anesthesia.4,11,12 In addition to the known risk
factors for thrombosis, the greatest risk factors for DVT
formation in patients undergoing laparoscopic cholecys-
tectomy are thought to be reverse Trendelenburg posi-
tioning and pneumoperitoneum with increased operative
times (greater than 2 hours).4,5 Pneumoperitoneum is
thought to increase the risk for DVT by decreasing
venous flow, thus resulting in diminished venous return
and decreased cardiac output.3 In addition, the reverse
Trendelenburg position decreases femoral venous blood
flow by as much as 42%.3
Despite the theoretical risk of thromboembolic disease due
to pneumoperitoneum and the reverse Trendelenburg
position, the frequency of reported DVT is low in
patients receiving DVT prophylaxis (either SCDs, LMWH,
or both).3 Ido et al1 reported an incidence of PE of 1 in
850 patients after laparoscopic cholecystectomy in
patients with no specific regimen for DVT prophylaxis.
Based on a Medline review of 78,747 patients,8 even the
highest estimated rates suggest the probability of the
most serious of the complications, including PE, is less
than 5 in 1000. In another report,10 the incidence of PE
after laparoscopic cholecystectomy was reported as 3 in
77,604. Our results correlate with these review papers in
that we have not identified any clinically significant DVT
or PE in our group of 587 patients. 
The diagnosis for DVT and PE reported in most pub-
lished prospective studies has been made within the first
week of surgery. Although pulmonary angiography is
necessary to diagnose PE, a variety of less invasive tech-
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diagnosis.11,12 Most of these studies used either comput-
ed tomography (CT) scan or ventilation perfusion scans
to make the diagnosis and then based results and recom-
mendations on these tests. Doppler instrumentation is an
accurate noninvasive method for diagnosing DVT, but
interpretation of the results is subjective and requires
experience for proficiency.12 When used alone, this test
provides few false-negatives but many false-positives.
The addition of duplex imaging does increase the accu-
racy of the examination.12 Because we did not use any
screening in asymptomatic patients, it is possible that a
number of our patients did form venous thrombosis with-
out our knowledge. Patel et al6 found an incidence of calf
vein thrombosis of 40% after laparoscopic cholecystecto-
my as diagnosed by routine duplex examination. With no
occurrence of PE despite their high rate of calf vein DVT,
we agree with their conclusion that the significance and
natural history of calf vein DVT in a healthy mobile pop-
ulation are not known.
Sufficient data exist to justify the use of DVT prophylaxis in
a high-risk population to prevent pulmonary embolism
(PE).12 Multiple regimens for DVT prophylaxis are used
in the high-risk population including compression stock-
ings, sequential compression devices, and low-dose
heparin (5000 units subcutaneously b.i.d.) or low molec-
ular weight heparin (eg. enoxaparin 1 mg/kg sq divided
b.i.d.). Studies have shown that compression stockings
are shown to only decrease the incidence of DVT by
10%.12 Taken twice daily, low-dose heparin reduced DVT
from 25% to 10%, and fatal PE from 0.7% to 0.2% in the
general surgery population.12
Although no one questions the need for DVT prophylax-
is during long, complicated cases, the need for prophy-
laxis in patients under 40 years of age with no known risk
factors undergoing uncomplicated operative procedures
may not be necessary.12 The NIH consensus study recent-
ly suggested that in low-risk patients with little chance of
DVT, early ambulation and SCDs are sufficient prophy-
laxis against DVT.12 Despite the theoretical risk of throm-
boembolic disease due to pneumoperitoneum in laparo-
scopic cholecystectomy, the frequency of clinically
detectable DVT is low.3 In our group of patients, it was
nonexistent. For these uncomplicated laparoscopic cases,
the minimally invasive nature and shorter recovery times
leading to quicker mobilization may result in a decrease
in DVT and pulmonary embolism as compared with that
in the general surgery population.4 Others have shown
that femoral blood flow quickly returns to baseline with
the release of pneumoperitoneum, suggesting that the
intraoperative release of pneumoperitoneum (every 30
minutes or so) would be sufficient to prevent thrombo-
sis.1
In the healthy population (especially patients younger
than 40 years) undergoing brief surgical procedures,
reports12 suggest that early ambulation may be sufficient
to prevent the formation of DVT and, therefore, PE. In
our experience, early ambulation was the only form of
DVT prophylaxis for 569 patients (with an average age of
45 years and anesthesia time of 84 minutes), none of
whom developed clinically significant DVT or PE. A
recent prospective study of 60 patients undergoing
uncomplicated laparoscopic procedures without any
DVT prophylaxis showed no development of DVT with
routine postoperative duplex screening, despite the doc-
umented decrease in venous flow of the lower extremi-
ties.2 All of these studies lead to the question of whether
or not DVT prophylaxis is truly indicated in otherwise
healthy patients undergoing routine laparoscopic chole-
cystectomy. 
The risks of DVT prophylaxis are dependent on the
method used. SCDs are an effective noninvasive method
for reducing DVT; however, they are often used inap-
propriately and inconsistently, thus negating their
effect.13 Coumadin and heparin each have a bleeding
risk and require monitoring of prothrombin time (PT)
and partial thromboplastin time (PTT). Recent improve-
ments in standard heparin treatment are the low-molec-
ular-weight heparin preparations. Enoxaparin, for exam-
ple is prepared from the degradation products of unfrac-
tionated porcine heparin.14 It exerts its effect on factor Xa
and antithrombin III but does not bind thrombin well,
thus preventing clots with less risk of bleeding.13-15 Large
studies have shown that when compared with heparin,
the low-molecular-weight heparins like enoxaparin show
no difference in DVT recurrence, bleeding incidence,
and mortality.13 Because prophylactic doses of LMWH do
not affect the PT or PTT, routine monitoring of these tests
is not required. However, cases have been reported of
severe hyperkalemia in patients after the initiation of
LMWH. This has prompted some authors to suggest rou-
tine monitoring of potassium, especially in patients with
diabetes, renal failure, and concomitant use of medica-
tions that alter potassium balance.16 Standard heparin
treatment can induce thrombocytopenia and delayed-
type hypersensitivity reactions due to antibody forma-
tion.14 In these patients with hypersensitivity, whenLMWH had been used as an alternative choice for anti-
coagulation, similar adverse reactions occurred.14 A dis-
tinct disadvantage of the LMWHs is that their half-lives
are long, and effects are not reversed by protamine. In
the event of bleeding, the only choice of treatment is
platelet transfusion, which decreases the drug’s receptor
occupancy on antithrombin III.15
The practice of using routine DVT prophylaxis regardless
of the individual risk factors can lead to a substantial
increase in the cost of the procedure. If the incidence of
DVT in laparoscopic cholecystectomy is truly low, is it
worth the cost of across the board prophylaxis? The cost
at our institution for SCDs is a $142.68 1-time charge.
This represents $81,898.32 for the entire group of
patients. Likewise, our patients are charged $17.23 per 30
mg subcutaneous dose of enoxaparin (3 perioperative
dosing charges of $51.69), representing a $29,670.06
charge for the group. Because no clinically detectable
evidence of DVT existed in our study group despite the
lack of any perioperative DVT prophylaxis, we question
whether DVT prophylaxis is indicated for routine laparo-
scopic cholecystectomy. 
CONCLUSION
We  believe that our observations of these 569 low-risk
patients who underwent laparoscopic cholecystectomy
without specific DVT prophylaxis correlate well with the
larger published reviews. Deep venous thrombosis and
pulmonary embolism are rare events following this pro-
cedure. A prospective trial, large enough to detect the
benefit of intervention, is required to finally answer the
question of whether all patients should be given DVT
prophylaxis during laparoscopic cholecystectomy. In the
mean time, we suggest using clinical judgment based on
individual risk factors to dictate any prophylactic regi-
men.
References:
1. Ido K, Suzuki T, Taniguchi Y, et al. Femoral vein stasis dur-
ing laparoscopic cholecystectomy: effects of graded elastic com-
pression leg bandages in preventing thrombus formation.
Gastrointest Endosc. 1995;42(2):151-155. 
2. Wazz G, Branicki F, Taji H, Chishty I. Influence of pneu-
moperitoneum on the deep venous system during laparoscopy.
JSLS. 2000;4(4):291-295. 
JSLS(2001)5:215-219 219
3. Lord R, Ling J, Hugh T, Coleman M, Doust B, Nivison-Smith
I. Incidence of deep vein thrombosis after laparoscopic vs. mini-
laparotomy cholecystectomy. Arch Surg. 1998;133:967-973. 
4. Mayol J, Vincent-Hamelin E, Sarmiento J, et al. Pulmonary
embolism following laparoscopic cholecystectomy: report of two
cases and review of the literature. Surg Endosc. 1994;8:214-217. 
5. Caprini J, Arcelus J, Laubach M, et al. Postoperative hyper-
coaguability and deep-vein thrombosis after laparoscopic chole-
cystectomy. Surg Endosc. 1995;9:304-309. 
6. Patel M, Hardman D, Nicholls D, Fischer C, Appleberg M.
The incidence of deep venous thrombosis after laparoscopic
cholecystectomy. Med J Aust. 1996;164:652-655. 
7. Jorgensen J, Hanel K, Lalak N, Hunt D, North L, Morris D.
Thromboembolic complications of laparoscopic cholecystecto-
my. BMJ. 1993;306:518-519. 
8. Shae J, Healey M, Berlin J, et al. Mortality and complications
with laparoscopic cholecystectomy. A meta-analysis. Ann Surg.
1996;224(5):609-620. 
9. Millard J, Hill B, Cook P, Fenoglio M, Stahlgren L.
Intermittent sequential pneumatic compression in prevention of
venous stasis associated with pneumoperitoneum during laparo-
scopic cholecystectomy. Arch Surg. 1993;128:914-919. 
10. Deziel D, Millikan K, Economou S, Doolas A, Ko S, Airan M.
Complications of laparoscopic cholecystectomy: a national sur-
vey of 4,292 hospitals and an analysis of 77,604 cases. Am J Surg.
1993;165:9-14. 
11. Persson A, Davis R, Villavicencio J. Deep venous thrombo-
sis and pulmonary embolism. Surg Clin North Am. 1991;71(6):
1195-1209. 
12. NIH Consensus Conference. Prevention of venous thrombo-
sis and pulmonary embolism. JAMA. 1986;256(6):744-749. 
13. Fiorica J. Prophylaxis and treatment of venous thromboem-
bolism. Surg Rounds. 2000;23(suppl):6-8.
14. Tonn M, Schaiff R, Kollef M. Enoxaparin-associated dermal
necrosis: a consequence of cross-reactivity with heparin-mediat-
ed anti-bodies. Ann Pharmacother. 1997;31:323-326. 
15. Skubas N, Despotis G, Vlasnic J, Moon M. Preoperative use
of enoxaparin and tirofiban: possible association with increase
bleeding post bypass. Anesth. 1999;91(3):869-872. 
16. Wiggam MI, Beringer TRO. Effect of low-molecular-weight
heparin on serum concentrations of potassium. Lancet.
1997;350:292-293. 
Acknowledgments: Special thanks to Mrs. Berta Turner for her
help and support.